#asc37 Tech News.
1 story in the last 7 days
The latest asc37 news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks asc37 across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
TechFinancial Timesabout 2 hours ago
Ascletis ASC37 Shows Superior Weight Loss in MiceAscletis announced ASC37, a once-monthly subcutaneous GLP-1R/GIPR/GCGR triple peptide agonist. In a diet-induced obese mouse model, ASC37 demonstrated superior weight loss compared to other treatments.
Summaries by ByteBrief